Skip to main content

IMMUNOLOGY2026™ Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Alexander Sigalov, PhD (he/him/his)

President and Principal Investigator
SignaBlok, Inc.

Poster(s):

(754) TREM-1-mediated modulation of innate immune response in acute and chronic inflammation: Effect of treatment timing and cell specificity on outcome

Saturday, April 18, 2026
2:30 PM - 3:30 PM US ET